AVITA Medical (RCEL) Cash from Investing Activities (2019 - 2025)

AVITA Medical has reported Cash from Investing Activities for 7 years, with the latest figure at $11000.0 in Q4 2025.

• For the quarter ending Q4 2025, Cash from Investing Activities fell 99.55% year-over-year to $11000.0; the trailing twelve-month figure through Dec 2025 stood at $12.5 million (down 66.67% YoY), and the FY2025 full-year result was $12.5 million, down 66.67% from the prior year.
• Cash from Investing Activities for Q4 2025 stood at $11000.0, up from -$5.3 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $21.8 million in Q3 2023, with the low at -$57.3 million in Q4 2023.
• Historically, Cash from Investing Activities has averaged -$1.5 million across 5 years, with a median of $2.5 million in 2024.
• Annual changes were most pronounced in 2021 — Cash from Investing Activities sank 16669.59% — and 2023, when it jumped 183.12%.
• AVITA Medical's Cash from Investing Activities stood at -$49.6 million in 2021, then surged by 93.64% to -$3.2 million in 2022, then tumbled by 1714.57% to -$57.3 million in 2023, then jumped by 104.31% to $2.5 million in 2024, then tumbled by 99.55% to $11000.0 in 2025.
• The last three Cash from Investing Activities figures came in at $11000.0 (Q4 2025), -$5.3 million (Q3 2025), and $7.0 million (Q2 2025), per Business Quant data.